Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.

BORIS DOI
Publisher DOI
PubMed ID
40014335
Description
This randomized clinical trial explores whether hormone intensification at start of androgen deprivation therapy alters selection of androgen receptor (AR) gene alterations within the gene body and/or enhancer region.
Date of Publication
2025-02-27
Publication Type
Article
Language(s)
en
Contributor(s)
Leone, Gianmarco
Orlando, Francesco
Dutey-Magni, Peter
Vainauskas, Osvaldas
Grist, Emily
Ciani, Yari
Lall, Sharanpreet
Thakali, Suparna
Wingate, Anna
Wetterskog, Daniel
Sachdeva, Ashwin
Sydes, Matthew R
McPhail, Neil
Sreenivasan, Thiagarajan
O'Sullivan, Joe M
Clarke, Noel W
Parmar, Mahesh K B
Brown, Louise C
James, Nicholas D
Attard, Gerhardt
Additional Credits
Series
JAMA Oncology
Publisher
American Medical Association
ISSN
2374-2445
2374-2437
Access(Rights)
restricted
Show full item